Background : Platelet activation has been implicated in the pathogenesis of a number of diseases, which include atherosclerosis, coronary vascular disease, and cerebrovascular disease. There have been controversies with the influence of hormone therapy on platelet activation. The purpose of this study was to define the effect of long-term hormone therapy on platelet activation. Methods : We recruited a total of 162 postmenopausal women aged 55 and above among wihch eighty healthy postmenopausal women had received hormone therapy for more than 5 years and the remaining eighty- two healthy postmenopausal women with no hormone therapyapy. Baseline characteristics as well as the parameters related to platelet activation were compared between...
OBJECTIVES: To evaluate effects of postmenopausal hormone replacement therapy (HRT) on von Willebran...
The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remains controvers...
Background: Oral contraceptive use increases risk for ve-nous thromboembolism, but data on the effec...
Background: Hormone replacement therapy (HRT) increases the risk of cardiovascular morbidity in post...
Background/aim: To examine the effects of hormone replacement therapy (HRT) on mean platelet volume ...
<div><p></p><p>Activated platelets serve as a catalyst for thrombin generation and a source of vasoa...
Background/aim: To examine the effects of hormone replacement therapy (HRT) on mean platelet volume ...
PubMed ID: 19060490Objectives: The aim of this study was to evaluate measures of insulin resistance ...
Objective: Recent large, prospective, randomized studies show that hormone therapy (HT) does not con...
SUMMARY. The effect of hormone replacement therapy (HRT) on platelet size was examined in 38 post-me...
Epidemiological studies have shown that hormone therapy (HT) increases the risk of venous thromboemb...
WOS: 000261385800008PubMed ID: 19060490Objectives: The aim of this study was to evaluate measures of...
Background: The platelet glycoprotein IIb/IIIa receptor is a key mediator of platelet aggregation an...
<p><strong>Abstract </strong></p> <p><strong>INTRODUCTION:</strong><strong> </strong>During ex...
Objective: Increased thrombin generation has emerged as a new surrogate marker of venous thromboembo...
OBJECTIVES: To evaluate effects of postmenopausal hormone replacement therapy (HRT) on von Willebran...
The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remains controvers...
Background: Oral contraceptive use increases risk for ve-nous thromboembolism, but data on the effec...
Background: Hormone replacement therapy (HRT) increases the risk of cardiovascular morbidity in post...
Background/aim: To examine the effects of hormone replacement therapy (HRT) on mean platelet volume ...
<div><p></p><p>Activated platelets serve as a catalyst for thrombin generation and a source of vasoa...
Background/aim: To examine the effects of hormone replacement therapy (HRT) on mean platelet volume ...
PubMed ID: 19060490Objectives: The aim of this study was to evaluate measures of insulin resistance ...
Objective: Recent large, prospective, randomized studies show that hormone therapy (HT) does not con...
SUMMARY. The effect of hormone replacement therapy (HRT) on platelet size was examined in 38 post-me...
Epidemiological studies have shown that hormone therapy (HT) increases the risk of venous thromboemb...
WOS: 000261385800008PubMed ID: 19060490Objectives: The aim of this study was to evaluate measures of...
Background: The platelet glycoprotein IIb/IIIa receptor is a key mediator of platelet aggregation an...
<p><strong>Abstract </strong></p> <p><strong>INTRODUCTION:</strong><strong> </strong>During ex...
Objective: Increased thrombin generation has emerged as a new surrogate marker of venous thromboembo...
OBJECTIVES: To evaluate effects of postmenopausal hormone replacement therapy (HRT) on von Willebran...
The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remains controvers...
Background: Oral contraceptive use increases risk for ve-nous thromboembolism, but data on the effec...